comprehensive -WSS

comprehensive

author：explore 2025-09-27 09:58:50 - browse：2727

Surgeons prepare the pig kidney for transplantation — Surgeons prepare the gene-edited pig kidney for transplantation at Massachusetts General Hospital. Massachusetts General Hospital

In a new test of xenotransplantation, a medical team at Massachusetts General Hospital announced Thursday that, for the first time, it had transplanted a kidney from a CRISPR gene-edited pig into a living patient.

Surgeons performed the milestone procedure over four hours on Saturday, March 16, without complications. The organ recipient, a 62-year-old man named Richard Slayman, had previously received a human kidney transplant, but it failed after about five years, requiring him to resume kidney dialysis in 2023.

As of Thursday morning, Slayman, a manager with the Massachusetts Department of Transportation, was up and walking — he’s up to 20 laps a day around the ward — one of his physicians told STAT. His kidneys are performing well enough that he hasn’t received dialysis since the surgery, said Leonardo Riella, MGH’s medical director for kidney transplants. He is expected to be discharged soon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Reconstructing family trees of blood cells may help predict disease

WSS

Colorectal cancer study finds potential in overlooked immune cell

Merck, Johnson & Johnson CEOs will testify on high drug prices

Merck, Johnson & Johnson CEOs will testify on high drug prices

New clues to why women have higher risk of autoimmune disorders

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Sana to lay off nearly a third of staff, de

Wikipedia

comprehensive

focus

Medicare proposal to cover medical devices draws a mixed reaction

A virus, fished out of a lake, may have saved a man’s life

Trump demands the U.S. pay no more for drugs than other countries … again

FDA panel signals lack of confidence in Amgen cancer drug data

Supreme Court strikes down use of affirmative action

AI can decode, harness the power of the humane immune system

Alkermes shareholders re

What to expect at HLTH 2023, the health care industry conference

Anesthesiologist group: stop taking Ozempic before surgery

Why age limits for politicians are a terrible idea

focus

Readout Newsletter: The latest on Novavax, Merck, Bluebird

FDA panel signals lack of confidence in Amgen cancer drug data

Bristol 'take

How generative AI ratchets up security threats for health systems

3 questions for the future of Biden's cancer moonshot

Why Medicare shouldn’t cover every FDA

knowledge

hotspot

focus

Wikipedia